News | Focused Ultrasound Therapy | January 27, 2016

Best-selling author uses book to raise awareness, funds for Focused Ultrasound Foundation

John Grisham book, The Tumor, focused ultrasound

January 27, 2016 — Bestselling author John Grisham has written "The Tumor," a fictional account of how a real medical technology could impact the future of medicine. The short book is about focused ultrasound, a non-invasive therapy with the potential to transform the treatment of a variety of serious medical disorders. The Kindle e-book is available for free on Amazon.

“It’s the most important book I’ve ever written,” said Grisham. “Everyone who is concerned about their health and loved ones should read 'The Tumor' to learn about a breakthrough medical technology. I have found no other cause, issue or charity that can potentially save so many lives.”

"The Tumor" follows the experience of the fictional patient Paul, an otherwise healthy 35-year-old father who is diagnosed with a malignant brain tumor. Despite receiving current state-of-the-art treatment of invasive brain surgery, radiation and chemotherapy, he passes away nine months after his diagnosis.

Grisham then takes readers to an alternate future, where Paul is diagnosed with the same brain tumor at 35 years old in the year 2025. In this future, doctors utilize focused beams of ultrasound energy to destroy Paul’s tumor without cutting into his skull. They then refocus the ultrasound to the surrounding brain to activate nanoparticles that deliver high concentrations of chemotherapy to the brain while minimizing systemic side effects. Paul is able to go back to his busy life after these procedures. The tumor returns a couple of times, and he is retreated with the same approach. While the tumor will eventually take Paul’s life, focused ultrasound therapy could transform a fatal condition into one that is chronic, but manageable.

Focused ultrasound uses ultrasonic energy guided by real-time imaging to treat tissue deep in the body without incisions or radiation. Multiple intersecting beams of ultrasound are directed and concentrated on a target, much like a magnifying glass can focus multiple beams of light on a single point. Where each individual beam passes through the tissue, there is no effect. But, at the focal point, the convergence of the beams of focused ultrasound energy results in many important biological effects depending on the nature of the tissue and the ultrasound parameters.

“John has been a board member and steadfast supporter of our foundation for years. We are fortunate to have such a noteworthy advocate helping to spread the word about this game-changing therapy,” said Neal F. Kassell, M.D., chairman of the Focused Ultrasound Foundation. “He wants to help ensure that focused ultrasound is part of our future. Though in its infancy, there is great potential for this technology to improve quality of life and decrease cost of care. But progress is too slow, and we want to help make it available sooner to help as many people as possible.”

Grisham wrote "The Tumor" to raise awareness and funds to help the Focused Ultrasound Foundation to accelerate the development and adoption of the technology to improve the lives of millions of people with serious medical disorders. While the book is free, he encourages the public to support the foundation’s programs for research, education and advocacy.

Today, focused ultrasound is approved in the United States to treat uterine fibroids, reduce pain from bone metastases and treat the prostate. Different systems are approved to treat 16 diseases in regions around the world. The technology is in various stages of research and development for more than 50 diseases, including Parkinson’s, Alzheimer’s, hypertension and tumors of the brain, liver, breast and pancreas.

For more information: www.thetumor.org


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now